,
, Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Disease Study, Lancet Infect Dis, vol.16, pp.584-91, 2013.
New world cutaneous leishmaniasis in travellers, Lancet Infect Dis, vol.6, pp.342-351, 2006. ,
,
, Épidémiologie des leishmanioses autochtones en France métropolitaine et d'outremer, Presse Med, vol.42, pp.1469-81, 2013.
Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP, Trop Med Health, vol.45, p.5, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01898045
,
, Traitement des leishmanioses en France : proposition d'un référentiel consensuel
, Presse Med, vol.40, pp.173-84, 2011.
Leishmaniasis among gold miners, French Guiana, Emerg Infect Dis, vol.12, pp.1169-70, 2006. ,
Épidémie de leishmaniose cutanée chez des militaires de retour de mission en Guyane, Rev Epidemiol Sante Publique, vol.54, pp.213-234, 2006. ,
Leishmaniose cutanée chez les militaires en opération en Guyane française, Med Trop, vol.60, pp.297-302, 2000. ,
,
, Synthèse de données militaires sur 10 ans, Med Trop, vol.62, pp.545-53, 2002.
Seasonal fluctuations of incubation, healing delays, and clinical presentation of cutaneous leishmaniasis in French Guiana, J Parasitol, vol.87, pp.1495-1503, 2001. ,
Leishmania spp. identification by polymerase chain reaction-restriction fragment length polymorphism analysis and its applications in French Guiana, Diagn Microbiol Infect Dis, vol.66, issue.2, pp.175-80, 2010. ,
Influence of clinical presentation on the efficacy of a short course of pentamidine in 16 the treatment of cutaneous leishmaniasis in French Guiana, Ann Trop Med Parasitol, vol.95, pp.331-337, 2001. ,
A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis, An Bras Dermatol, vol.86, pp.1092-101, 2011. ,
,
Presence of Leishmania RNA Virus 1 in Leishmania guyanensis increases the risk of first-line treatment failure and symptomatic relapse, J Infect Dis, vol.213, pp.105-116, 2016. ,
Diagnosis and treatment of leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the, Clin Infect Dis, vol.63, pp.1539-57, 2016. ,
Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate, Am J Trop Med Hyg, vol.65, pp.456-65, 2001. ,
Influence of meteorological parameters on the clinical presentation of cutaneous leishmaniasis in French Guiana and on the efficacy of pentamidine treatment of the disease, Ann Trop Med Parasitol, vol.96, pp.773-80, 2002. ,
Association of the endobiont double-stranded RNA Virus LRV1 with treatment failure for human leishmaniasis caused by Leishmania braziliensis in Peru and Bolivia, J Infect Dis, vol.213, pp.112-133, 2016. ,
Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer, Clin Infect Dis, vol.34, pp.69-73, 2002. ,
In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment, J Infect Dis, vol.199, pp.576-585, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00911620
Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana, Br J Dermatol, vol.151, pp.1165-71, 2004. ,
Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru, Clin Infect Dis, vol.46, pp.223-254, 2008. ,
LR1: a candidate RNA virus of, Leishmania Proc Natl Acad Sci, vol.85, pp.9572-9577, 1988. ,
,
, Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis, Science, vol.331, pp.775-783, 2011.
Leishmania RNA virus: when the host pays the toll, Front Cell Infect Microbiol, vol.2, p.99, 2012. ,
Comparison of Leishmania typing results obtained from 16 European clinical laboratories in 2014, Euro Surveill, vol.21, 2016. ,
Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis, J Antimicrob Chemother, vol.51, pp.1319-1339, 2003. ,
Rhabdomyolyse induite par l'iséthionate de pentamidine (Pentacarinat®) lors du traitement d'une leishmaniose cutanée : 2 cas, Ann Dermatol Venereol, vol.129, pp.50-52, 2002. ,
Safe and Effective Prophylaxis with Bimonthly Intravenous Pentamidine in the Pediatric Hematopoietic Stem Cell Transplant Population, Pediatr Infect Dis J, vol.35, pp.135-176, 2016. ,
Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation, Pediatr Infect Dis J, vol.32, pp.933-939, 2013. ,
Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana, Ann Trop Med Parasitol, vol.100, pp.307-321, 2006. ,
,
, Thérapeutique des leishmanioses tégumentaires du Nouveau Monde. Expérience à propos de 326 cas traités par iséthionate de pentamidine à fortes doses, Med Trop, vol.63, pp.35-44, 2003.
Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname, Int J Dermatol, vol.48, pp.52-60, 2009. ,
,
, Recurrent American cutaneous leishmaniasis. Emerg Infect Dis, vol.13, pp.1436-1444, 2007.
Isoenzyme characterization of 112 Leishmania isolates from French Guiana, Trans R Soc Trop Med Hyg, vol.83, pp.610-612, 1989. ,
,
, Prevalence and Distribution of Leishmania RNA Virus 1 in Leishmania parasites from French Guiana, Am J Trop Med Hyg, vol.94, pp.102-108, 2016.